It’s Finally Over for Aduhelm, the Sketchy Alzheimer’s Drug Everyone Hated
Biogen is abandoning its lackluster Alzheimer’s disease drug, Aduhelm. The Massachusetts-based company announced Wednesday that it is pulling the medication from the market following poor sales and controversy over its…